Male sex accelerates cognitive decline in GBA1 Parkinson's disease

被引:0
|
作者
Caminiti, Silvia Paola [1 ]
Avenali, Micol [1 ,2 ]
Galli, Alice [3 ]
Malito, Rachele [2 ]
Cuconato, Giada [4 ]
Galandra, Caterina [2 ]
Calabrese, Rosaria [2 ]
Pilotto, Andrea [3 ,5 ]
Padovani, Alessandro [3 ,5 ]
Blandini, Fabio [1 ,6 ]
Perani, Daniela [7 ]
Tassorelli, Cristina [1 ,2 ]
Valente, Enza Maria [2 ,4 ]
机构
[1] Univ Pavia, Dept Brain & Behav Sci, Pavia, Italy
[2] IRCCS C Mondino Fdn, Pavia, Italy
[3] Univ Brescia, Dept Clin & Expt Sci, Neurol Unit, Brescia, Italy
[4] Univ Pavia, Dept Mol Med, Pavia, Italy
[5] ASST Spedali Civili Brescia, Dept Continu Care & Frailty, Neurol Unit, Brescia, Italy
[6] Osped Maggiore Policlin, Ca Granda Fdn, Milan, Italy
[7] IRCCS San Raffaele Sci Inst, Milan, Italy
关键词
SLEEP BEHAVIOR DISORDER; QUALITY-OF-LIFE; DEMENTIA; IMPAIRMENT; CRITERIA; BIOMARKERS; MUTATIONS; MODELS; RISK; AGE;
D O I
10.1038/s41531-025-00883-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We evaluated 128 GBA and 432 nonGBA Parkinson's disease (PD) subjects available from Parkinson's Progression Markers Initiative. Baseline clinical features and dopaminergic activity were assessed, together with clinical follow-up (6.87 +/- 3.2 years). Survival analyses assessed the independent and interactive effects of sex and GBA1 mutations on cognitive decline. At baseline, GBA-PD males showed severe motor impairment, sleep disorders and memory deficits. Despite milder motor deficit, compared to GBA-PD males, GBA-PD females showed greater dopaminergic denervation, suggesting the effect of neural reserve. In longitudinal assessment, GBA-PD males showed greater MoCA rate of change per year and greater risk of cognitive impairment than GBA-PD females and nonGBA-PD. In GBA-PD males, both late age at onset and "severe/mild" GBA variants were associated with increased risk of cognitive impairment. Male sex and GBA1 carrier status have an additive value in increasing the risk of cognitive decline in PD. The effect of sex on GBA1-related pathology warrants further examination to address future trials design and patients' selection.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Expanding Views of Mitochondria in Parkinson's Disease: Focusing on PINK1 and GBA1 Mutations
    Yuan, Yu
    Ma, Xizhen
    Song, Ning
    Xie, Junxia
    NEUROSCIENCE BULLETIN, 2022, 38 (7) : 825 - 828
  • [32] Lack of full sequencing GBA1 studies for patients with Parkinson's disease in Latin America
    Lopes Santos-Lobato, Bruno
    Schumacher-Schuh, Artur F.
    Mata, Ignacio F.
    NPJ PARKINSONS DISEASE, 2022, 8 (01)
  • [33] Lack of full sequencing GBA1 studies for patients with Parkinson’s disease in Latin America
    Bruno Lopes Santos-Lobato
    Artur F. Schumacher-Schuh
    Ignacio F. Mata
    npj Parkinson's Disease, 8
  • [34] Contrasting Olfactory Perception in Parkinson's disease (PD): Impact of GBA1 Gene Mutations
    Schechter, Y.
    Dominko, M.
    Cohen, M.
    Yahalom, G.
    Zimran, A.
    Revel-Vilk, S.
    Shulman, E.
    Dinur, T.
    Cohen, M. Becker
    MOVEMENT DISORDERS, 2024, 39 : S140 - S140
  • [35] Mutational spectrum and clinical features of GBA1 variants in a Chinese cohort with Parkinson’s disease
    Yangjie Zhou
    Yige Wang
    Juan Wan
    Yuwen Zhao
    Hongxu Pan
    Qian Zeng
    Xun Zhou
    Runcheng He
    Xiaoxia Zhou
    Yaqin Xiang
    Zhou Zhou
    Bin Chen
    Qiying Sun
    Qian Xu
    Jieqiong Tan
    Lu Shen
    Hong Jiang
    Xinxiang Yan
    Jinchen Li
    Jifeng Guo
    Beisha Tang
    Heng Wu
    Zhenhua Liu
    npj Parkinson's Disease, 9
  • [36] Reply to: "Could Blood Hexosylsphingosine Be a Marker for Parkinson's Disease Linked with GBA1 Mutations"?
    Surface, Matthew
    Balwani, Manisha
    Waters, Cheryl
    Haimovich, Alexander
    Gan-Or, Ziv
    Marder, Karen S.
    Hsieh, Tammy
    Song, Linxia
    Padmanabhan, Shalini
    Hsieh, Frank
    Merchant, Kalpana M.
    Alcalay, Roy N.
    MOVEMENT DISORDERS, 2022, 37 (08) : 1782 - 1782
  • [37] Mapping the GBA1 gene rare variants and their effects in a Hungarian Parkinson's Disease Cohort
    Szlepak, Tamas
    Kossev, Annabel Plamen
    Csaban, Dora
    Illes, Anett
    Borsos, Beata
    Balicza, Peter
    Grosz, Zoltan
    Takats, Annamaria
    Klivenyi, Peter
    Molnar, Maria Judit
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2022, 30 (SUPPL 1) : 297 - 297
  • [38] Generation of GBA1 isogenic iPSC lines to investigate the pathogenesis of GBA1-associated Parkinson disease
    Ma, Charis
    Chen, Yu
    Chen, Chase
    Sidransky, Ellen
    MOLECULAR GENETICS AND METABOLISM, 2024, 141 (02)
  • [39] Sex distribution and classification of GBA1 variants in an Italian cohort of Parkinson's disease patients analyzed over the last seventeen years
    Panteghini, Celeste
    Reale, Chiara
    Colangelo, Isabel
    Suerz, Marta
    Catania, Alessia
    Garavaglia, Barbara
    Invernizzi, Federica
    PARKINSONISM & RELATED DISORDERS, 2023, 117
  • [40] The Molecular Impact of Glucosylceramidase Beta 1 (Gba1) in Parkinson's Disease: a New Genetic State of the Art
    dos Santos, Julio Cesar Claudino
    Mano, Gabriela Braga Cabrera
    da Cunha Barreto-Vianna, Andre Rodrigues
    Garcia, Tulia Fernanda Meira
    de Vasconcelos, Aline Vieira
    Sa, Caio Sergio Gomes
    de Souza Santana, Sarah Lopes
    Farias, Ana Gabriela Ponte
    Seimaru, Beatriz
    Lima, Micael Porto Portela
    Goes, Joao Vitor Caetano
    Gusmao, Camilla Teixeira Pinheiro
    Ribeiro Junior, Howard Lopes
    MOLECULAR NEUROBIOLOGY, 2024, 61 (09) : 6754 - 6770